HIV prevalence among populations of men who have sex with men and transgender women in Cambodia, 1999–2019. by Jan W. de Lind van Wijngaarden (5488949)

Subjects:

PRISMA flow diagram of identified, screened, eligible and included publications. by Jan W. de Lind van Wijngaarden (5488949)

Subjects:

Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years in Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years by age group in Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal. by Shyam Raj Upreti (4451614)

Subjects:

Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type^a and age group, in Ontario, Canada, 2007-2017^b. by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

Serotype distribution of invasive pneumococcal disease cases^a, by associated vaccine type, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

Number of confirmed invasive pneumococcal disease cases, by associated vaccine type^a and year, in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

Subjects:

Incidence rates (per 100,000 population) of commonly^a reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017. by Shinthuja Wijayasri (8124539)

Subjects:

Sociodemographic characteristics and intervention assignment, post-training sample. by Kathryn E. L. Grimes (9202013)

Subjects:

Outcome measures collected from trainees via tablet in pre- and post-training surveys. by Kathryn E. L. Grimes (9202013)

Subjects:

EFA and CFA results for the final 6-item self-efficacy to resist unwanted advances scale. by Kathryn E. L. Grimes (9202013)

Subjects:

EFA and CFA results for the final 8-item bystander intentions scale. by Kathryn E. L. Grimes (9202013)

Subjects:

EFA and CFA results for the final 8-item date rape attitudes scale. by Kathryn E. L. Grimes (9202013)

Subjects:

EFA and CFA results for the final 12-item risky and protective dating behaviors scale. by Kathryn E. L. Grimes (9202013)

Subjects:

VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

Subjects:

Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020). by Abigail K. Korn (12096012)

Subjects:

Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

Subjects: